100 related articles for article (PubMed ID: 8028749)
1. [Factor VIII/Ag (von Willebrand) and protein C. Erythrocyte deformability and aggregability. The risk parameters of retinal vein occlusion].
Cortinovis A; Crippa A; Crippa M
Minerva Med; 1994 May; 85(5):211-9. PubMed ID: 8028749
[TBL] [Abstract][Full Text] [Related]
2. Hemorheology, plasma protein composition and von Willebrand factor in type I diabetic nephropathy.
Zimmermann J; Schramm L; Wanner C; Mulzer E; Henrich HA; Langer R; Heidbreder E
Clin Nephrol; 1996 Oct; 46(4):230-6. PubMed ID: 8905207
[TBL] [Abstract][Full Text] [Related]
3. [Increase of erythrocyte aggregation in retinal vein occlusion].
Glacet-Bernard A; Chabanel A; Coscas G; Lelong F; Samama M
J Fr Ophtalmol; 1990; 13(10):500-5. PubMed ID: 2081840
[TBL] [Abstract][Full Text] [Related]
4. [Erythrocyte aggregation and retinal vein occlusion. Preliminary data for a randomized study on the efficacy of anti-erythrocyte aggregation (troxerutin) in retinal vein occlusion].
Glacet-Bernard A; Coscas G; Lelong F; Chabanel A; Samama M; Taccoen A
Bull Soc Ophtalmol Fr; 1989 Dec; 89(12):1393-6. PubMed ID: 2632113
[TBL] [Abstract][Full Text] [Related]
5. Branch retinal vein occlusion: the pathogenetic role of blood viscosity.
Piermarocchi S; Segato T; Bertoja H; Midena E; Zucchetto M; Girolami A; Procidano M; Mares M
Ann Ophthalmol; 1990 Aug; 22(8):303-11. PubMed ID: 2221710
[TBL] [Abstract][Full Text] [Related]
6. Role of haemorheological factors in patients with retinal vein occlusion.
Sofi F; Mannini L; Marcucci R; Bolli P; Sodi A; Giambene B; Menchini U; Gensini GF; Abbate R; Prisco D
Thromb Haemost; 2007 Dec; 98(6):1215-9. PubMed ID: 18064316
[TBL] [Abstract][Full Text] [Related]
7. Activated protein C resistance is a risk factor for central retinal vein occlusion.
Marcucci R; Bertini L; Liotta AA; Rogolino A; Antonucci E; Ilari I; Pepe G; Prisco D
Ann Ital Med Int; 2000; 15(3):195-8. PubMed ID: 11059059
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between hemorheology and pro- and anti-coagulation factors in inflammatory and degenerative vascular diseases].
Cortinovis A; Crippa A; Crippa M
Minerva Med; 1994 Sep; 85(9):439-49. PubMed ID: 7936365
[TBL] [Abstract][Full Text] [Related]
9. [Blood rheology and fibrinogenemia: two independent parameters in the assessment of cerebral vascular damage].
Cortinovis A; Crippa A; Crippa M
Minerva Med; 1995 Dec; 86(12):511-8. PubMed ID: 8684676
[TBL] [Abstract][Full Text] [Related]
10. Hemorheologic abnormalities associated with HIV infection: altered erythrocyte aggregation and deformability.
Kim A; Dadgostar H; Holland GN; Wenby R; Yu F; Terry BG; Meiselman HJ
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3927-32. PubMed ID: 16936106
[TBL] [Abstract][Full Text] [Related]
11. [Retinal vein occlusion and resistance to activated protein C].
Scat Y; Morin Y; Morel C; Haut J
J Fr Ophtalmol; 1995; 18(12):758-62. PubMed ID: 8745708
[TBL] [Abstract][Full Text] [Related]
12. Relationships between von Willebrand factor and hemorheology in sportsmen.
Melnikov AA; Vikulov AD; Bagrakova SV
Clin Hemorheol Microcirc; 2003; 29(1):19-24. PubMed ID: 14561900
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of hemorheological risk factor profile in plasmacytoma patients.
Ramakrishnan S; Grebe R; Singh M; Schmid-Schönbein H
Clin Hemorheol Microcirc; 1999; 20(1):11-9. PubMed ID: 11185678
[TBL] [Abstract][Full Text] [Related]
14. Protein Z levels and central retinal vein or artery occlusion.
Koren-Michowitz M; Eting E; Rahimi-Levene N; Garach-Jehoshua O; Volcheck Y; Kornberg A
Eur J Haematol; 2005 Nov; 75(5):401-5. PubMed ID: 16191090
[TBL] [Abstract][Full Text] [Related]
15. Haemorheological changes in patients with retinal vein occlusion after isovolaemic haemodilution.
Wiek J; Schade M; Wiederholt M; Arntz HR; Hansen LL
Br J Ophthalmol; 1990 Nov; 74(11):665-9. PubMed ID: 2223704
[TBL] [Abstract][Full Text] [Related]
16. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
17. Stress-induced hyperviscosity in the pathophysiology of takotsubo cardiomyopathy.
Cecchi E; Parodi G; Giglioli C; Passantino S; Bandinelli B; Liotta AA; Bellandi B; Cioni G; Costanzo M; Abbate R; Gensini GF; Antoniucci D; Mannini L
Am J Cardiol; 2013 May; 111(10):1523-9. PubMed ID: 23465096
[TBL] [Abstract][Full Text] [Related]
18. Red blood cell deformability, aggregability and cytosolic calcium concentration in normal tension glaucoma.
Vetrugno M; Cicco G; Cantatore F; Arnese L; Delle Noci N; Sborgia C
Clin Hemorheol Microcirc; 2004; 31(4):295-302. PubMed ID: 15567900
[TBL] [Abstract][Full Text] [Related]
19. [Hemorheologic and coagulation study in a group of patients with diabetic retinopathy].
Parenti M; Pasquali R; Sorrenti G; Babini AC; Melchionda N; Palareti G; Poggi M; Tricarico G
G Clin Med; 1984; 65(9-10):409-18. PubMed ID: 6442246
[No Abstract] [Full Text] [Related]
20. Elevated erythrocyte aggregation in patients with central retinal vein occlusion and without conventional risk factors.
Glacet-Bernard A; Chabanel A; Lelong F; Samama MM; Coscas G
Ophthalmology; 1994 Sep; 101(9):1483-7. PubMed ID: 8090451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
